bpc-157 human clinical studies If worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of bpc-157 human clinical trials evidence
Description
All PSPeptides products are sold exclusively for laboratory and research use
The stated recommended daily consumption amount must not be exceeded
Egrifta and the related Egrifta SV and Egrifta WR formulations are Health Canada-approved or FDA-approved prescription drug products manufactured to pharmaceutical standards and supplied for human therapeutic use under prescription
If you are thinking about a peptide stack, research potential interactions first
In the STEP 1 trial, semaglutide led to an average 14.9% reduction in body weight over 68 weeks , far outperforming placebo (NEJM study on semaglutide for weight loss)
They also run dedicated mens and womens peptide programs, which is rare in a category that mostly defaults to male-optimizer marketing
